Researchers have created nanoscale robots which could be used to manage bleeds in the brain caused by aneurysms. The development could enable precise, relatively low-risk treatment of brain aneurysms, which cause around 500,000 deaths globally each year. The medical condition—a blood-filled bulge on a brain artery that can rupture and cause fatal bleeds—can also lead to stroke and disability.
The study points to a future where tiny robots could be remotely controlled to carry out complex tasks inside the human body—such as targeted drug delivery and organ repair—in a minimally invasive way, researchers say.
Swarming bots
The team, involving researchers from the University of Edinburgh, engineered magnetic nanorobots—about a twentieth the size of a human red blood cell—comprising blood-clotting drugs encased in a protective coating, designed to melt at precise temperatures. The work is published in the journal Small.
In lab tests, several hundred billion such bots were injected into an artery and then remotely guided as a swarm, using magnets and medical imaging, to the site of an aneurysm.
Magnetic sources outside the body then cause the robots to cluster together inside the aneurysm and be heated to their melting point, releasing a naturally occurring blood-clotting protein, which blocks the aneurysm to prevent or stem bleeding into the brain.
Lab trials
The international team, co-led by clinicians from Shanghai Sixth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine in China, successfully tested their devices in model aneurysms in the lab and in a small number of rabbits.
The team says that nanorobots show potential for transporting and releasing drug molecules to precise locations in the body without risk of leaking into the bloodstream—a key test of the technology’s safety and efficacy.
The study could pave the way for further developments towards trials in people.
Promising potential
Their advancement could improve on current treatments for brain aneurysms. Typically, doctors thread a tiny microcatheter tube along blood vessels before using it to insert metal coils to stem the aneurysm blood flow, or a mesh tube called a stent, to divert the bloodstream in the artery.
Researchers say their new technique could decrease the risk that the body will reject implanted materials, and curb reliance on anti-blood-clotting drugs, which can cause bleeding and stomach problems.
The method also avoids the need for doctors to manually shape a microcatheter to navigate a complex network of small blood vessels in the brain to reach the aneurysm—a painstaking task which may take hours during surgery, researchers say.
Larger brain aneurysms—which can be difficult to stem quickly and safely using metal coils or stents—could potentially be treated using the new technique too.
The study was led by a team from the UK and China who have also developed nanorobots to remove blood clots, which show potential in treating stroke.
“Nanorobots are set to open new frontiers in medicine—potentially allowing us to carry out surgical repairs with fewer risks than conventional treatments and target drugs with pinpoint accuracy in hard-to-reach parts of the body. Our study is an important step towards bringing these technologies closer to treating critical medical conditions in a clinical setting,” Dr. Qi Zhou.
More information: Jienan Wang et al, Nanoarchitectonic Engineering of Thermal‐Responsive Magnetic Nanorobot Collectives for Intracranial Aneurysm Therapy, Small (2024). DOI: 10.1002/smll.202400408
Journal information: Small
Provided by University of Edinburgh
News
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
